MétaCan
Menu
Back to cohort
Record W3162925121 · doi:10.1101/2020.10.06.323162

CancerVar: an Artificial Intelligence empowered platform for clinical interpretation of somatic mutations in cancer

2020· preprint· en· W3162925121 on OpenAlexaff
Quan Li, Zilin Ren, Kajia Cao, Marilyn M. Li, Kai Wang, Yunyun Zhou

Bibliographic record

VenuebioRxiv (Cold Spring Harbor Laboratory) · 2020
Typepreprint
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGenomics and Rare Diseases
Canadian institutionsPrincess Margaret Cancer CentreUniversity of TorontoUniversity Health Network
FundersU.S. National Library of MedicineNational Institute of General Medical SciencesNational Human Genome Research InstituteNational Institutes of Health
KeywordsClinical significanceArtificial intelligenceMachine learningComputer scienceCancerSomatic cellInterpretation (philosophy)Computational biologyBioinformaticsMedicineBiologyGeneticsGenePathology

Abstract

fetched live from OpenAlex

ABSTRACT Several knowledgebases, such as CIViC and OncoKB, have been manually curated to support clinical interpretations of a limited number of “hotspot” somatic mutations in cancer, yet discrepancies or even conflicting interpretations have been observed among these knowledgebases. Additionally, while these knowledgebases have been extremely useful, they typically cannot interpret novel mutations, which may also have functional and clinical impacts in cancer. To address these challenges, we developed an automated interpretation tool called CancerVar (Cancer Variants interpretation) to score more than 12.9 million somatic mutations and classify them into four tiers: strong clinical significance, potential clinical significance, uncertain clinical significance, and benign/likely benign, based on the AMP/ASCO/CAP 2017 guideline. Considering that the AMP/ASCO/CAP rule-based scoring system may have inherent limitations, such as lack of a clear guidance on weighing different pieces of functional evidence or unclear definition for certain clinical evidence, it may cause misinterpretation for certain variants that have functional impacts but no proven clinical significance. To address this issue, we further introduced a deep learning-based scoring system to predict oncogenicity of mutations by semi-supervised generative adversarial network (SGAN) method using both functional and clinical evidence. We trained and validated the SGAN model on 5,234 somatic mutations from an in-house database of clinical reports on cancer patients, and achieved a good performance when testing on 6,226 variants that were curated by us through literature search. We also compared the prediction with several independent datasets and showed great utility in classifying variants with previously unknown interpretations. CancerVar is also incorporated into a web server that can generate automated texts with summarized descriptive interpretations, such as diagnostic, prognostic, targeted drug responses and clinical trial information for many hotspot mutations. In summary, CancerVar can facilitate clinical interpretation and hypothesis generation for somatic mutations, and greatly reduce manual workload for retrieving relevant evidence and implementing existing guidelines.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.013
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: none
GenreCandidate signal: Software · Consensus signal: none
Teacher disagreement score0.006
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.013
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0050.002
Science and technology studies0.0000.000
Scholarly communication0.0020.001
Open science0.0020.003
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0060.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.055
GPT teacher head0.338
Teacher spread0.283 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSimulation or modeling
Domainnot available
GenreSoftware

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2020
Admission routes1
Has abstractyes

Explore more

Same venuebioRxiv (Cold Spring Harbor Laboratory)Same topicGenomics and Rare DiseasesFrench-language works237,207